Eli Lilly: Price drops, share price rises
The shares of the pharmaceutical company Eli Lilly are one of the long-distance runners on the stock market. For years, the stock has practically only been going up. Today, too, the shares are continuing to rise. The company announced that it would reduce the prices of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. This will please patients and could lead to higher sales figures.
The company is introducing 7.5-milligram single-dose vials for $499 per month and 10-milligram single-dose vials for $499 per month. The drug giant is also cutting the price of 2.5-milligram and 5-milligram vials of Zepbound, which is very popular among patients. But the drug has also been criticized for its high cost. Lilly announced it would cut the price of the 2.5-milligram dose to $349 per month and the price of the 5-milligram dose to $499 per month.
"Every major medical organization and institution recognizes obesity as a chronic disease, yet insurance and government programs do not systematically cover medical care for people with obesity - this must change," said Patrik Jonsson, executive vice president and president of Lilly Cardiometabolic Health and Lilly USA.
The company has recently been able to attract attention with its decent figures. However, after the rise in recent years, the share is anything but a bargain. Even if Eli Lilly reaches the upper end of the forecast, the share is valued at a 2025 P/E ratio of almost 40. DER AKTIONÄR currently sees a much better entry opportunity in Danish rival Novo Nordisk. The Danes also reported strong figures for the fourth quarter and the full year. The share is also showing a firm performance today .
Statistically speaking, investing in stocks is one of the safest ways to build wealth over the years. So why do so many people still think the stock market is a casino and buying stocks is wild gambling? Stock market expert Andreas Lipkow explains. He shows how you can actually invest successfully on the stock market - but also which methods and strategies either don't work or no longer work. "Successful strategic investing" is the perfect book for anyone who wants to acquire the knowledge to successfully increase their money on the stock market.
deraktionaer.de
